IRSN, Institut de radioprotection et de sûreté nucléaire

Search our site :


Contact us :

En Fr

Enhancing Nuclear Safety



Effect of U3O8 specific surface area on in vitro dissolution, biokinetics, and dose coefficients

V. Chazel, P. Houpert and E. Ansoborlo
Radiat. Prot. Dosim. 1998, 79(1-4), pp 39-42
WORKSHOP ON INTAKES OF RADIONUCLIDES: Occupational and Public Exposure - Proceedings of a Workshop held in Avignon, France. September 15-18 1997

Document type > *Article de revue, *Congrès/colloque

Keywords > radiotoxicology, uranium

Research Unit > LEAR_(Laboratory for applied studies on radiotoxicology)

Authors > HOUPERT Pascale

Publication Date > 01/01/1998


The purpose of this study was to investigate the effect of the specific surface area (SSA) of U3O8, sampled from different processes, on its in vitro dissolution, its biokinetics in rats, and dose coefficient. A knowledge of the manufacturing process as well as the physico-chemical properties of uranium oxides are necessary to understand why the solubility and consequently the dose may vary for the same chemical form of a compound. Eight preparations of U3O8 with different SSA, have been characterised. In vitro chemical dissolution tests, in culture medium, have shown an increase of solubility with SSA. In vivo experiments involving intratracheal deposition of a suspension of the oxides showed that the amount of uranium absorbed into blood increased 3-fold when the SSA increased 5-fold. Calculations of the dose coefficients from in vitro dissolution parameters, have shown a decrease from 4.30 to 1.75 µSv.Bq-1 when the SSA increased from 0.7 to 15.5 m2.g-1. Dose coefficients calculated from in vivo absorption parameters varied from 5.5 to 4.2 µSv.Bq-1, when the SSA increased from 0.7 to 3.2 m2.g-1.
Send Print

More information


Send to a friend

The information you provide in this page are single use only and will not be saved.
* Required fields

Recipient's email:*  

Sign with your name:* 

Type your email address:*   

Add a message :

Do you want to receive a copy of this email?